Power to Disrupt: Clinical Diagnostics Now comes to Oxford
15 September, 2026
Point of care testing, artificial intelligence and new diagnostic pathways will take centre stage at Power to Disrupt: Clinical Diagnostics Now in Oxford on Monday 16th November 2026.
Point of care testing is moving rapidly from isolated innovation to an increasingly important part of modern clinical pathways. As healthcare services look for faster results, more accessible testing and better use of clinical information, the challenge is turning new technology into safe, practical and scalable practice.
Power to Disrupt: Clinical Diagnostics Now will bring together professionals working across point of care testing, pathology, blood sciences, diagnostics and clinical innovation for a full day of insight, discussion and networking.
The provisional programme will explore:
-
Diagnostics in the new NHS world.
-
Core competencies for biomedical scientists working in POCT.
-
New molecular testing approaches for sexually transmitted infections and norovirus.
-
How artificial intelligence could change the focus of diagnostics.
-
The opportunities and challenges behind the diagnostic revolution.
-
Transforming gestational diabetes screening through POCT.
-
Improving the UTI diagnostic pathway for clinical, cost and patient benefit.
The agenda also includes sessions on syndromic multiplex PCR testing and full blood count measurement at the point of care, alongside exhibition and networking opportunities.
The event is relevant to POCT leads and managers, biomedical scientists, clinical scientists, pathology and blood sciences teams, diagnostics and innovation professionals, clinicians and organisations supporting the development of testing services.
Monday 16th November 2026
Leonardo Royal Hotel, Oxford
View the full programme and booking information here:
The provisional programme is subject to change.
